TelyRx Holdings Inc. saw a significant drop in its stock price, closing down 8.24% in the last trading session.
TelyRx Holdings Inc. (TELY.TO) experienced a sharp decline in its stock value, closing at CA$2.34, down 8.24% from the previous day. This downturn raises questions about the company's recent performance and future outlook.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$73.09M
52W high
$4.25
52W low
$2.00
1W change
+10.20%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 122.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+122.2% Upside
Current Price
C$2.70
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.6%
Annualized
90-Day Vol
97.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.26
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.54 | C$1.79 โ C$3.62 |
| 60 trading days | C$2.40 | C$1.45 โ C$3.95 |
| 90 trading days | C$2.26 | C$1.22 โ C$4.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as TelyRx Holdings faces challenges despite recent revenue growth, with a notable increase in net losses indicating potential underlying issues.
TelyRx Holdings Inc. down 8.24% in one day
The company's market cap now stands at CA$67.8 million, reflecting investor concerns amid rising losses.
Bull case
TelyRx has shown promising revenue growth, with Q1 2026 revenues reaching CA$19.4 million. This suggests that the company is expanding its market presence and customer base.
Bear case
Even though TelyRx's revenue has increased, its net loss has also grown, which could signal deeper financial troubles and affect investor confidence moving forward.
Recent Performance Overview
In the last trading session, TelyRx Holdings Inc. saw its stock price drop by 8.24%, closing at CA$2.34. This decline comes amidst a backdrop of increasing revenue but also escalating net losses, raising concerns among investors about the company's financial health. For more details, check out the TELY.TO stock page.
Financial Health and Future Outlook
Despite reporting a revenue increase to CA$19.4 million in Q1 2026, TelyRx's net loss expanded to CA$4.7 million, up from CA$3.1 million in the previous quarter. This trend could indicate potential challenges ahead for the company. Investors should consider these factors carefully when evaluating their positions in TELY.TO. For further insights, visit our TelyRx Holdings Inc. page.
Advertisement
